Overview
Pulmonary atresia with ventricular septal defect (PA-VSD), also known as pulmonary atresia with VSD or tetralogy of Fallot with pulmonary atresia, is a complex congenital heart defect in which the pulmonary valve fails to form properly, completely blocking blood flow from the right ventricle to the pulmonary artery, combined with a hole between the two lower chambers of the heart (ventricular septal defect). This condition is considered the most severe form of tetralogy of Fallot. Because blood cannot travel through the normal pulmonary artery pathway to the lungs, the body relies on alternative blood vessels called major aortopulmonary collateral arteries (MAPCAs) or a patent ductus arteriosus to supply blood to the lungs for oxygenation. The anatomy of the pulmonary blood supply is highly variable among affected individuals. Infants with PA-VSD typically present shortly after birth with cyanosis (bluish discoloration of the skin due to low oxygen levels), rapid breathing, difficulty feeding, and failure to thrive. The severity of symptoms depends largely on the source and adequacy of pulmonary blood flow. Some patients may have well-developed native pulmonary arteries, while others rely entirely on MAPCAs, which can lead to uneven blood flow distribution to the lungs. Without treatment, the condition is life-threatening. Treatment is surgical and often requires a staged approach. Initial management in neonates may include prostaglandin infusion to maintain ductal patency and ensure adequate pulmonary blood flow. Surgical interventions include placement of a modified Blalock-Taussig shunt, unifocalization of MAPCAs (connecting collateral vessels to create a unified pulmonary blood supply), VSD closure, and placement of a right ventricle-to-pulmonary artery conduit. The specific surgical strategy depends on the individual anatomy of the pulmonary arteries and collateral vessels. Long-term follow-up is essential, as patients often require multiple surgeries or catheter-based interventions throughout their lives, including conduit replacements. Outcomes have improved significantly with advances in surgical techniques, though the prognosis varies depending on the complexity of the pulmonary vascular anatomy.
Variable
Can be inherited in different ways depending on the underlying gene
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Pulmonary atresia with ventricular septal defect.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Pulmonary atresia with ventricular septal defect at this time.
New trials open frequently. Follow this disease to get notified.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Pulmonary atresia with ventricular septal defect.
Community
No community posts yet. Be the first to share your experience with Pulmonary atresia with ventricular septal defect.
Start the conversation →Latest news about Pulmonary atresia with ventricular septal defect
No recent news articles for Pulmonary atresia with ventricular septal defect.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Pulmonary atresia with ventricular septal defect
What is Pulmonary atresia with ventricular septal defect?
Pulmonary atresia with ventricular septal defect (PA-VSD), also known as pulmonary atresia with VSD or tetralogy of Fallot with pulmonary atresia, is a complex congenital heart defect in which the pulmonary valve fails to form properly, completely blocking blood flow from the right ventricle to the pulmonary artery, combined with a hole between the two lower chambers of the heart (ventricular septal defect). This condition is considered the most severe form of tetralogy of Fallot. Because blood cannot travel through the normal pulmonary artery pathway to the lungs, the body relies on alternati
At what age does Pulmonary atresia with ventricular septal defect typically begin?
Typical onset of Pulmonary atresia with ventricular septal defect is neonatal. Age of onset can vary across affected individuals.
Which specialists treat Pulmonary atresia with ventricular septal defect?
6 specialists and care centers treating Pulmonary atresia with ventricular septal defect are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.